Breaking News Instant updates and real-time market news.

2020-06-09 08:06:31 FDS FactSet $314.86 / -2.6 (-0.82%) 08:06 06/09/20 06/09 08:06 06/09/20 08:06	FactSet price target raised to $260 from $225 at DA Davidson DA Davidson analyst Peter Heckmann raised the firm's price target on FactSet to $260 from $225 and keeps a Neutral rating on the shares ahead of its Q3 results. The analyst expects the company to meet or modestly exceed forecasts and the management should affirm its guidance given that FactSet is well-positioned to weather the pandemic impacts with "high levels of recurring revenue", limited direct exposure, solid profit margins, and a strong balance sheet. After a 17% year-to-date gains, FactSet is now trading at 20- to 21-times his expected 2021 EBITDA, Heckmann adds, which is above the long-term average of 14-times.	25 Jun
FDS FactSet $314.86 / -2.6 (-0.82%) 06/03/20 Deutsche Bank FactSet price target raised to $293 from $237 at Deutsche Bank 03/27/20 DA Davidson FactSet price target lowered to $225 from $240 at DA Davidson 03/27/20 Cantor Fitzgerald FactSet price target raised to $258 from $240 at Cantor Fitzgerald 01/07/20 Morgan Stanley Morgan Stanley resets Business & Education Services preferences with 4 upgrades

2020-06-09 08:06:31

FDS

FactSet

$314.86 / -2.6 (-0.82%)

08:06

06/09/20

06/09

08:06

06/09/20

08:06

FactSet price target raised to $260 from $225 at DA Davidson

DA Davidson analyst Peter Heckmann raised the firm's price target on FactSet to $260 from $225 and keeps a Neutral rating on the shares ahead of its Q3 results. The analyst expects the company to meet or modestly exceed forecasts and the management should affirm its guidance given that FactSet is well-positioned to weather the pandemic impacts with "high levels of recurring revenue", limited direct exposure, solid profit margins, and a strong balance sheet. After a 17% year-to-date gains, FactSet is now trading at 20- to 21-times his expected 2021 EBITDA, Heckmann adds, which is above the long-term average of 14-times.

25
Jun

FDS FactSet

$314.86 / -2.6 (-0.82%)

06/03/20 Deutsche Bank: FactSet price target raised to $293 from $237 at Deutsche Bank

03/27/20 DA Davidson: FactSet price target lowered to $225 from $240 at DA Davidson

03/27/20 Cantor Fitzgerald: FactSet price target raised to $258 from $240 at Cantor Fitzgerald

01/07/20 Morgan Stanley: Morgan Stanley resets Business & Education Services preferences with 4 upgrades

TODAY'S FREE FLY STORIES

Technical Analysis	Consumer Discretionary Sector SPDR: Pivot points » 08:24 03/02/21 03/02 08:24 03/02/21 08:24 XLY Consumer Discretionary Sector SPDR $164.93 / +3.67 (+2.28%) The following are the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Options Technical Analysis XLY Consumer Discretionary Sector SPDR $164.93 / +3.67 (+2.28%) 03/18/20 Jefferies ups Health Care to Overweight, cuts Discretionary to Underweight XLY Consumer Discretionary Sector SPDR $164.93 / +3.67 (+2.28%) 02/19/21 Unusually active option classes on open February 19th 11/18/20 Unusually active option classes on open November 18th 11/16/20 Unusually active option classes on open November 16th XLY Consumer Discretionary Sector SPDR $164.93 / +3.67 (+2.28%) 03/01/21 Consumer Discretionary Sector SPDR: Pivot points 02/26/21 On The Fly: Weekly technical notes for S&P 500 02/26/21 Consumer Discretionary Sector SPDR: Pivot points 02/25/21 Consumer Discretionary Sector SPDR: Pivot points
Technical Analysis	S&P Select Materials SPDR: Pivot points » 08:24 03/02/21 03/02 08:24 03/02/21 08:24 XLB S&P Select Materials SPDR $75.40 / +1.85 (+2.52%) The following are the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Options Technical Analysis XLB S&P Select Materials SPDR $75.40 / +1.85 (+2.52%) 06/10/20 Jefferies Jefferies downgrades Tech sector to Market Weight from Overweight XLB S&P Select Materials SPDR $75.40 / +1.85 (+2.52%) 01/06/21 Largest borrow rate increases among liquid names 10/29/20 Unusually active option classes on open October 29th XLB S&P Select Materials SPDR $75.40 / +1.85 (+2.52%) 03/01/21 S&P Select Materials SPDR: Pivot points 02/26/21 S&P Select Materials SPDR: Pivot points 02/25/21 S&P Select Materials SPDR: Pivot points 02/24/21 S&P Select Materials SPDR: Pivot points
Recommendations	Sarepta price target lowered to $132 from $143 at RBC Capital » 08:24 03/02/21 03/02 08:24 03/02/21 08:24 SRPT Sarepta $86.94 / -0.07 (-0.08%) RBC Capital analyst Brian… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events SRPT Sarepta $86.94 / -0.07 (-0.08%) 02/25/21 Sarepta rallies 2% to $86.15 after winning FDA approval for DMD treatment 02/25/21 Sarepta announces FDA approval of Amondys 45 02/08/21 Dyne Therapeutics appoints Ashish Dugar as SVP, global head of medical affairs 01/13/21 Sarepta, Genevant announce collaboration for gene editing therapeutics SRPT Sarepta $86.94 / -0.07 (-0.08%) 05:05 Today Piper Sandler Sarepta price target lowered to $130 from $140 at Piper Sandler 02/26/21 Mizuho Sarepta price target raised to $160 from $158 at Mizuho 02/25/21 Piper Sandler Piper says Sarepta's Amondys 45 approval comes with 'relatively clean label' 02/09/21 Morgan Stanley Sarepta denied motion to dismiss 'Wilson Wolf' case, says Morgan Stanley SRPT Sarepta $86.94 / -0.07 (-0.08%) 03/01/21 Sarepta reports Q4 EPS ($1.84), consensus ($1.77) 03/01/21 Sarepta reports Q4 EPS ($1.84), consensus ($1.77) 11/05/20 Sarepta reports Q3 EPS ($2.50), consensus ($1.71) SRPT Sarepta $86.94 / -0.07 (-0.08%) 03/01/21 Fly Intel: After-Hours Movers 01/12/21 NIO downgrade, Wells Fargo upgrade among today's top calls on Wall Street 01/08/21 Fly Intel: Wall Street's top stories for Friday 01/08/21 Fly Intel: Wall Street's top stories at midday 00:00 Today 41st Annual Healthcare Virtual Conference
Technical Analysis	Utilities SPDR: Pivot points » 08:23 03/02/21 03/02 08:23 03/02/21 08:23 XLU Utilities SPDR $59.61 / +1.26 (+2.16%) The following are the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Technical Analysis XLU Utilities SPDR $59.61 / +1.26 (+2.16%) 10/21/20 Jefferies Jefferies upgrades Utilities sector to Market Weight from Underweight 10/19/20 Goldman Sachs Essential Utilities upgraded to Conviction Buy from Neutral at Goldman Sachs XLU Utilities SPDR $59.61 / +1.26 (+2.16%) 03/01/21 Utilities SPDR: Pivot points 02/26/21 On The Fly: Weekly technical notes for S&P 500 02/26/21 Utilities SPDR: Pivot points 02/25/21 Utilities SPDR: Pivot points
Conference/Events	Tailwind Acquisition to host business news update conference call » 08:23 03/02/21 03/02 08:23 03/02/21 08:23 TWND Tailwind Acquisition $10.89 / +0.34 (+3.22%) Management of QOMPLX and… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< On The Fly TWND Tailwind Acquisition $10.89 / +0.34 (+3.22%) 09/06/20 Opening Day: PainReform raises $23M in Nasdaq IPO

Recommendations	Precigen price target raised to $14 from $10 at B. Riley Securities » 08:23 03/02/21 03/02 08:23 03/02/21 08:23 PGEN Precigen $8.20 / -0.25 (-2.96%) B. Riley Securities… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Options PGEN Precigen $8.20 / -0.25 (-2.96%) 01/05/21 Precigen announces FDA clearance of IND application for PRGN-2012 12/07/20 Precigen: PRGN-3006 safe, well-tolerated to date 11/16/20 Precigen announces dosing of first patients in ongoing PRGN-3005, -3006 trials 10/15/20 Precigen's UltraPorator system receives FDA clearance PGEN Precigen $8.20 / -0.25 (-2.96%) 02/25/21 Stifel Precigen initiated with a Buy at Stifel 02/22/21 Wells Fargo Precigen initiated with an Overweight at Wells Fargo 02/18/21 Fly Intel: Top five analyst initiations 02/18/21 B. Riley Securities Precigen initiated with a Buy at B. Riley Securities PGEN Precigen $8.20 / -0.25 (-2.96%) 03/01/21 Precigen reports Q4 EPS (22c), consensus (17c) 11/09/20 Precigen reports Q3 EPS (18c), consensus (14c) 22 Jan PGEN Precigen $8.20 / -0.25 (-2.96%) 01/21/21 Fly Intel: After-Hours Movers PGEN Precigen $8.20 / -0.25 (-2.96%) 12/11/20 Largest borrow rate increases among liquid names
Technical Analysis	Consumer Staples Sector SPDR: Pivot points » 08:23 03/02/21 03/02 08:23 03/02/21 08:23 XLP Consumer Staples Sector SPDR $63.94 / +0.65 (+1.03%) The following are the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Technical Analysis XLP Consumer Staples Sector SPDR $63.94 / +0.65 (+1.03%) 03/01/21 Consumer Staples Sector SPDR: Pivot points 02/26/21 Consumer Staples Sector SPDR: Pivot points 02/25/21 Consumer Staples Sector SPDR: Pivot points 02/24/21 Consumer Staples Sector SPDR: Pivot points
Technical Analysis	Health Care Select Sector SPDR: Pivot points » 08:23 03/02/21 03/02 08:23 03/02/21 08:23 XLV Health Care Select Sector SPDR $114.01 / +1.35 (+1.20%) The following are the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Options Technical Analysis XLV Health Care Select Sector SPDR $114.01 / +1.35 (+1.20%) 03/18/20 Jefferies ups Health Care to Overweight, cuts Discretionary to Underweight XLV Health Care Select Sector SPDR $114.01 / +1.35 (+1.20%) 02/19/21 Unusually active option classes on open February 19th 01/11/21 Opening put Seller in Health Care SPDR ETF 10/30/20 Largest borrow rate increases among liquid names XLV Health Care Select Sector SPDR $114.01 / +1.35 (+1.20%) 03/01/21 Health Care Select Sector SPDR: Pivot points 02/26/21 On The Fly: Weekly technical notes for S&P 500 02/26/21 Health Care Select Sector SPDR: Pivot points 02/25/21 Health Care Select Sector SPDR: Pivot points
Technical Analysis	iShares Trust Russell 2000 Index Fund: Pivot points » 08:22 03/02/21 03/02 08:22 03/02/21 08:22 IWM iShares Trust Russell 2000 Index Fund $226.15 / +7.85 (+3.60%) The following are the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Periodicals Technical Analysis IWM iShares Trust Russell 2000 Index Fund $226.15 / +7.85 (+3.60%) 11/25/20 Partial shutdown in Germany extended amid virus uptick, Bloomberg says 10/13/20 UK science experts say brief lockdown would prevent Covid-19 deaths, FT reports IWM iShares Trust Russell 2000 Index Fund $226.15 / +7.85 (+3.60%) 03/01/21 iShares Trust Russell 2000 Index Fund: Pivot points 02/26/21 On The Fly: Weekly technical notes for Russell 2000 02/26/21 iShares Trust Russell 2000 Index Fund: Pivot points 02/25/21 iShares Trust Russell 2000 Index Fund: Pivot points
Technical Analysis	Diamonds Fund ETF: Pivot points » 08:22 03/02/21 03/02 08:22 03/02/21 08:22 DIA Diamonds Fund ETF $315.49 / +6.11 (+1.97%) The following are the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Periodicals Options Technical Analysis DIA Diamonds Fund ETF $315.49 / +6.11 (+1.97%) 11/25/20 Partial shutdown in Germany extended amid virus uptick, Bloomberg says 11/23/20 Biden to nominate Janet Yellen for Treasury Secretary,WSJ says 10/13/20 UK science experts say brief lockdown would prevent Covid-19 deaths, FT reports 09/21/20 UK coronavirus alert level to be raised from 3 to 4, Guardian reports DIA Diamonds Fund ETF $315.49 / +6.11 (+1.97%) 02/17/21 Unusually active option classes on open February 17th 10/06/20 Unusually active option classes on open October 6th DIA Diamonds Fund ETF $315.49 / +6.11 (+1.97%) 03/01/21 Diamonds Fund ETF: Pivot points 02/26/21 Diamonds Fund ETF: Pivot points 02/25/21 Diamonds Fund ETF: Pivot points 02/24/21 Diamonds Fund ETF: Pivot points

Hot Stocks	Acutus Medical receives Vizient innovative technology contract » 08:22 03/02/21 03/02 08:22 03/02/21 08:22 AFIB Acutus Medical $21.37 / +0.59 (+2.84%) Acutus Medical announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate AFIB Acutus Medical $21.37 / +0.59 (+2.84%) 08:16 Today Acutus Medical appoints Duane Wilder as CCO 02/09/21 Acutus Medical appoints David Roman CFO 12/10/20 Acutus Medical announces CE Mark, European launch of AcQCross Transseptal System 12/07/20 Acutus Medical launches AcQBlate Force Sensing Ablation System in Europe AFIB Acutus Medical $21.37 / +0.59 (+2.84%) 01/14/21 BofA Acutus Medical downgraded to Neutral from Buy at BofA 08/31/20 Fly Intel: Top five analyst initiations 08/31/20 JPMorgan Acutus Medical initiated with an Overweight at JPMorgan 08/31/20 William Blair Acutus Medical initiated with an Outperform at William Blair AFIB Acutus Medical $21.37 / +0.59 (+2.84%) 01/13/21 Acutus Medical sees 2020 revenue $8.3M-$8.5M, consensus $10.97M 01/13/21 Acutus Medical sees Q4 revenue $2.4M-$2.6M, consensus $5.05M 11/12/20 Acutus Medical reports Q3 EPS ($1.95), consensus (99c) 09/17/20 Acutus Medical reports Q2 EPS ($32.24) vs ($45.70) last year 06 Aug
Technical Analysis	SPDR S&P 500 ETF Trust: Pivot points » 08:21 03/02/21 03/02 08:21 03/02/21 08:21 SPY SPDR S&P 500 ETF Trust $389.53 / +9.18 (+2.41%) The following are the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals Options Technical Analysis SPY SPDR S&P 500 ETF Trust $389.53 / +9.18 (+2.41%) 02/16/21 Jana Partners buys TreeHouse Foods, exits Callaway in Q4 02/16/21 Starboard Value buys ON Semi, cuts Advance Auto stake in Q4 02/01/21 Robinhood raises $3.4B to continue investing in customer growth 01/26/21 Biden announces plans for U.S. to buy 200M extra COVID-19 doses SPY SPDR S&P 500 ETF Trust $389.53 / +9.18 (+2.41%) 01/07/21 Credit Suisse Credit Suisse raises 2021 S&P 500 target to 4,200, sees 12% upside 11/09/20 JPMorgan JPMorgan sees S&P 500 hitting 4,000 by early next year 09/01/20 Fed's Brainard says monetary policy to pivot from stabilization to accommodation 08/17/20 Goldman Sachs Goldman boosts end of 2020 S&P 500 target to 3,600 from 3,000 SPY SPDR S&P 500 ETF Trust $389.53 / +9.18 (+2.41%) 02/28/21 House approves Biden's $1.9T COVID aid, Reuters reports 02/26/21 FDA panel says J&J COVID-19 vaccine benefits outweigh risks, CNBC says 02/26/21 House set to pass $1.9T COVID-19 stimulus package, CNBC reports 02/11/21 White House secures deals for additional 200M COVID-19 vaccine doses, CNBC says SPY SPDR S&P 500 ETF Trust $389.53 / +9.18 (+2.41%) 11/09/20 Options markets on track for record option volume SPY SPDR S&P 500 ETF Trust $389.53 / +9.18 (+2.41%) 03/01/21 SPDR S&P 500 ETF Trust: Pivot points 02/26/21 On The Fly: Weekly technical notes for S&P 500 02/26/21 On The Fly: ETF fund flow highlights 02/26/21 SPDR S&P 500 ETF Trust: Pivot points
Technical Analysis	Financial Select Sector: Pivot points » 08:21 03/02/21 03/02 08:21 03/02/21 08:21 XLF Financial Select Sector $33.31 / +1.02 (+3.16%) The following are the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Options Technical Analysis XLF Financial Select Sector $33.31 / +1.02 (+3.16%) 11/04/20 Unusually active option classes on open November 4th 10/05/20 Size blocks in Financial Sector SPDR ETF 10/01/20 Size year-end call spread sale in Financial Sector ETF XLF Financial Select Sector $33.31 / +1.02 (+3.16%) 03/01/21 Financial Select Sector: Pivot points 02/26/21 On The Fly: Weekly technical notes for S&P 500 02/26/21 On The Fly: ETF fund flow highlights 02/26/21 Financial Select Sector: Pivot points
Downgrade	FibroGen downgraded to Hold at Jefferies on increased risk for roxadustat » 08:21 03/02/21 03/02 08:21 03/02/21 08:21 FGEN FibroGen / + As previously reported,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options FGEN FibroGen / + 03/01/21 FibroGen, AstraZeneca report FDA to hold AdCom meeting to review roxadustat NDA 12/22/20 FibroGen doses first patient in ZEPHYRUS-2 Phase 3 study of pamrevlumab 12/19/20 AstraZeneca updates on U.S. regulatory review of roxadustat 12/18/20 FibroGen says FDA extends review period for roxadustat NDA FGEN FibroGen / + 06:24 Today Citi FibroGen selloff on FDA panel a buying opportunity, says Citi 04:47 Today Jefferies FibroGen downgraded to Hold from Buy at Jefferies 02/01/21 H.C. Wainwright FibroGen initiated with a Buy at H.C. Wainwright 12/21/20 Mizuho FibroGen should be bought on PDUFA extension weakness, says Mizuho FGEN FibroGen / + 03/01/21 FibroGen reports Q4 EPS (64c), consensus (24c) 11/05/20 FibroGen reports Q3 EPS 35c, consensus (80c) FGEN FibroGen / + 03/01/21 Fly Intel: After-Hours Movers 12/21/20 Fly Intel: Wall Street's top stories for Monday 12/21/20 Fly Intel: Wall Street's top stories at midday 12/21/20 Fly Intel: Pre-market Movers 00:00 Today 41st Annual Healthcare Virtual Conference 03/20/21 PDUFA Date for Roxadustat--Extended Date FGEN FibroGen / + 10/12/20 Unusually active option classes on open October 12th
Technical Analysis	Market Vectors Semiconductor: Pivot points » 08:21 03/02/21 03/02 08:21 03/02/21 08:21 SMH Market Vectors Semiconductor $248.22 / +7.13 (+2.96%) The following are the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Periodicals Technical Analysis SMH Market Vectors Semiconductor $248.22 / +7.13 (+2.96%) 11/25/20 Partial shutdown in Germany extended amid virus uptick, Bloomberg says 11/23/20 Biden to nominate Janet Yellen for Treasury Secretary,WSJ says SMH Market Vectors Semiconductor $248.22 / +7.13 (+2.96%) 03/01/21 Market Vectors Semiconductor: Pivot points 02/26/21 Market Vectors Semiconductor: Pivot points 02/25/21 Market Vectors Semiconductor: Pivot points 02/24/21 Market Vectors Semiconductor: Pivot points

Hot Stocks	Royal Bank of Canada selects FactSet as market data, tech provider » 08:21 03/02/21 03/02 08:21 03/02/21 08:21 RY Royal Bank of Canada $86.76 / +1.67 (+1.96%) , FDS FactSet $311.54 / +7.78 (+2.56%) FactSet (FDS) announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings RY FDS RY Royal Bank of Canada $86.76 / +1.67 (+1.96%) 02/24/21 Royal Bank of Canada reports Q1 ROE of 18.6%, up 100 bps y/y 01/28/21 Alliance Data: Bread announces technology partnership with Royal Bank of Canada 12/04/20 RBC now accepting applications for Canada's expanded CEBA loan program 12/02/20 Royal Bank of Canada reports Q4 CET1 ratio 12.5%, up 40 bps vs. last year FDS FactSet $311.54 / +7.78 (+2.56%) 02/18/21 FactSet launches integration with Microsoft Teams 02/08/21 FactSet appoints Vinay Kapoor as Chief Diversity, Equity & Inclusion Officer 01/26/21 FactSet launches Vermillion portfolio reporting solution in Japan 01/12/21 FactSet announces expanded offering with Snowflake RY FDS RY Royal Bank of Canada $86.76 / +1.67 (+1.96%) 06:05 Today BofA Royal Bank of Canada downgraded to Neutral from Buy at BofA 03/01/21 Argus Royal Bank of Canada price target raised to $100 from $92 at Argus 02/26/21 Desjardins Royal Bank of Canada price target raised to C$119 from C$117 at Desjardins 02/25/21 Canaccord Royal Bank of Canada price target raised to C$123 from C$116 at Canaccord FDS FactSet $311.54 / +7.78 (+2.56%) 12/22/20 Morgan Stanley FactSet price target raised to $278 from $269 at Morgan Stanley 09/25/20 Deutsche Bank FactSet price target raised to $315 from $293 at Deutsche Bank 09/25/20 UBS FactSet price target raised to $313 from $298 at UBS 06/26/20 DA Davidson FactSet price target raised to $288 from $260 at DA Davidson RY FDS RY Royal Bank of Canada $86.76 / +1.67 (+1.96%) 02/24/21 Royal Bank of Canada reports Q1 diluted EPS C$2.66, up 11% y/y 12/02/20 Royal Bank of Canada reports Q4 diluted EPS C$2.23 vs. C$2.18 a year ago FDS FactSet $311.54 / +7.78 (+2.56%) 12/21/20 FactSet backs FY21 adjusted EPS view $10.75-$11.15, consensus $11.04 12/21/20 FactSet reports Q1 adjusted EPS $2.88, consensus $2.75 09/24/20 FactSet sees 2021 adjusted EPS $10.75-$$11.15, consensus $10.84 09/24/20 FactSet reports Q4 adjusted EPS $2.88, consensus $2.54
Downgrade	Switch downgraded to Outperform from Strong Buy at Raymond James » 08:21 03/02/21 03/02 08:21 03/02/21 08:21 SWCH Switch $17.69 / +0.33 (+1.90%) Raymond James analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly SWCH Switch $17.69 / +0.33 (+1.90%) 03/01/21 Switch drops about 7% to $16.51 after reporting mixed Q4 results 09/16/20 Switch appoints Angela Archon to Board of Directors, effective November 4 SWCH Switch $17.69 / +0.33 (+1.90%) 04:44 Today Raymond James Switch downgraded to Outperform from Strong Buy at Raymond James 02/02/21 Truist sees Switch positioned for long-term growth, starts at Buy 02/02/21 Truist Switch initiated with a Buy at Truist 01/13/21 Jefferies Switch upgraded to Buy on earnings growth inflection at Jefferies SWCH Switch $17.69 / +0.33 (+1.90%) 03/01/21 Switch sees FY21 revenue $540M-$555M, consensus $588.3M 03/01/21 Switch reports Q4 adjusted EPS 6c, consensus 5c 11/05/20 Switch sees FY20 revenue $510M-$518M, consensus $516.47M 11/05/20 Switch reports Q3 EPS 5c, consensus 4c SWCH Switch $17.69 / +0.33 (+1.90%) 03/01/21 Fly Intel: After-Hours Movers
Technical Analysis	Invesco QQQ Trust: Pivot points » 08:20 03/02/21 03/02 08:20 03/02/21 08:20 QQQ Invesco QQQ Trust $323.61 / +9.28 (+2.95%) The following are the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Periodicals Options Technical Analysis QQQ Invesco QQQ Trust $323.61 / +9.28 (+2.95%) 11/25/20 Partial shutdown in Germany extended amid virus uptick, Bloomberg says 11/23/20 Biden to nominate Janet Yellen for Treasury Secretary,WSJ says 10/13/20 UK science experts say brief lockdown would prevent Covid-19 deaths, FT reports 09/21/20 UK coronavirus alert level to be raised from 3 to 4, Guardian reports QQQ Invesco QQQ Trust $323.61 / +9.28 (+2.95%) 12/21/20 Massive put spread in Nasdaq ETF rolls position opened August 25th 10/01/20 $18M call Buyer in the Qs delta neutral may be stock replacement QQQ Invesco QQQ Trust $323.61 / +9.28 (+2.95%) 03/01/21 Invesco QQQ Trust: Pivot points 02/26/21 Invesco QQQ Trust: Pivot points 02/25/21 Invesco QQQ Trust: Pivot points 02/24/21 Invesco QQQ Trust: Pivot points
Downgrade	Foot Locker downgraded to Hold from Buy at Williams Trading » 08:20 03/02/21 03/02 08:20 03/02/21 08:20 FL Foot Locker $51.65 / +3.395 (+7.04%) Williams Trading analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options FL Foot Locker $51.65 / +3.395 (+7.04%) 02/26/21 Foot Locker says will continue to assess 'opportunistic share buybacks' 02/26/21 Foot Locker says saw sequential improvement as Q4 progressed 02/26/21 Foot Locker drops 10% to $47.45 after Q4 revenue misses estimates 02/17/21 Foot Locker approves FY21 CapEx of $275M FL Foot Locker $51.65 / +3.395 (+7.04%) 03/01/21 Baird Foot Locker short-term trading setup looks attractive, says Baird 03/01/21 Barclays Foot Locker price target raised to $52 from $44 at Barclays 02/22/21 Fly Intel: Top five analyst initiations 02/22/21 Fly Intel: Top five analyst upgrades FL Foot Locker $51.65 / +3.395 (+7.04%) 02/26/21 Foot Locker reports Q4 EPS $1.55, consensus $1.35 02/25/21 Notable companies reporting before tomorrow's open 02/25/21 Notable companies reporting before tomorrow's open 11/20/20 Foot Locker reports Q3 EPS $1.21, consensus 62c FL Foot Locker $51.65 / +3.395 (+7.04%) 02/26/21 Fly Intel: Wall Street's top stories for Friday 02/26/21 Fly Intel: Wall Street's top stories at midday 02/26/21 Fly Intel: Pre-market Movers 02/22/21 Airbnb, Snap upgrades among today's top calls on Wall Street 03/30/21 Foot Locker FL Foot Locker $51.65 / +3.395 (+7.04%) 11/20/20 Unusually active option classes on open November 20th 11/17/20 Foot Locker call volume above normal and directionally bullish 11/16/20 Foot Locker call volume above normal and directionally bullish 10/16/20 Foot Locker call volume above normal and directionally bullish
Technical Analysis	Nasdaq Composite: Pivot points » 08:20 03/02/21 03/02 08:20 03/02/21 08:20 $COMP Nasdaq Composite $0.00 / + (+0.00%) The following are the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Technical Analysis $COMP Nasdaq Composite $0.00 / + (+0.00%) 03/01/21 Nasdaq Composite: Pivot points 02/26/21 Nasdaq Composite: Pivot points 02/25/21 Nasdaq Composite: Pivot points 02/24/21 Nasdaq Composite: Pivot points

Hot Stocks	Avadel Pharmaceuticals announces publication on FT218 studies » 08:20 03/02/21 03/02 08:20 03/02/21 08:20 AVDL Avadel Pharmaceuticals $8.31 / +0.25 (+3.10%) Avadel Pharmaceuticals… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events AVDL Avadel Pharmaceuticals $8.31 / +0.25 (+3.10%) 03/01/21 Avadel Pharmaceuticals announces FDA acceptance of FT218 NDA 02/17/21 Avadel Pharmaceuticals appoints Richard Kim as CCO 12/16/20 Avadel Pharmaceuticals announces NDA submission for FT218 12/07/20 Avadel appoints Jennifer Gudeman as VP, medical and clinical affairs AVDL Avadel Pharmaceuticals $8.31 / +0.25 (+3.10%) 01/25/21 Craig-Hallum Avadel Pharmaceuticals assumed with a Buy rating at Craig-Hallum 08/28/20 Oppenheimer Uwarranted pressure creates buying opportunity for Avadel, says Oppenheimer 08/28/20 SVB Leerink Avadel selloff on Jazz competition worries overdone, says SVB Leerink 07/31/20 Fly Intel: Top five analyst initiations AVDL Avadel Pharmaceuticals $8.31 / +0.25 (+3.10%) 11/09/20 Avadel Pharmaceuticals reports Q3 EPS (20c), consensus (25c) 29 Apr AVDL Avadel Pharmaceuticals $8.31 / +0.25 (+3.10%) 11/09/20 Fly Intel: Pre-market Movers 03/16/21 31st Annual Healthcare Virtual Conference 03/09/21 Avadel Pharmaceuticals - AVDL
Technical Analysis	Nasdaq 100 Index: Pivot points » 08:20 03/02/21 03/02 08:20 03/02/21 08:20 NDX Nasdaq 100 Index $0.00 / + (+0.00%) The following are the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Periodicals Technical Analysis NDX Nasdaq 100 Index $0.00 / + (+0.00%) 09/04/20 SoftBank's options purchase fuled major market rally, WSJ says 09/04/20 SoftBank revealed to be 'Nasdaq whale' fueling tech rally, FT says NDX Nasdaq 100 Index $0.00 / + (+0.00%) 03/01/21 Nasdaq 100 Index: Pivot points 02/26/21 Nasdaq 100 Index: Pivot points 02/25/21 Nasdaq 100 Index: Pivot points 02/24/21 Nasdaq 100 Index: Pivot points
Recommendations	Okta price target raised to $300 from $264 at RBC Capital » 08:19 03/02/21 03/02 08:19 03/02/21 08:19 OKTA Okta $269.63 / +7.8 (+2.98%) RBC Capital analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options OKTA Okta $269.63 / +7.8 (+2.98%) 12/02/20 Okta jumps 6.8% to $246 after Q3 results, FY21 guidance, AWS availability 12/02/20 Okta announces availability of Identity Cloud in AWS Marketplace 12/02/20 Okta names Mike Kourey CFO 10/09/20 Okta CEO: Customer identity is our second big business OKTA Okta $269.63 / +7.8 (+2.98%) 02/23/21 Deutsche Bank Okta initiated with a Buy at Deutsche Bank 02/17/21 Mizuho Okta price target raised to $305 from $270 at Mizuho 02/16/21 Canaccord Okta price target raised to $300 from $250 at Canaccord 02/11/21 Oppenheimer Okta assumed with an Outperform at Oppenheimer OKTA Okta $269.63 / +7.8 (+2.98%) 12/02/20 Okta guides FY22 revenue $1.06B-$1.07B, consensus $1.05B 12/02/20 Okta raises FY21 EPS view to 4c-5c from (3c)-(1c), consensus (1c) 12/02/20 Okta sees Q4 adjusted EPS (2c)-(1c), consensus (2c) 12/02/20 Okta reports Q3 adjusted EPS 4c, consensus (1c) OKTA Okta $269.63 / +7.8 (+2.98%) 12/21/20 Analysts move to sidelines on SolarWinds following cyberattack 12/09/20 JPMorgan downgrades Zoom, upgrades Autodesk in software ratings shakeup 12/02/20 Fly Intel: After-Hours Movers 12/01/20 Fly Intel: What to watch in Salesforce's earnings report 03/03/21 Okta - OKTA OKTA Okta $269.63 / +7.8 (+2.98%) 12/02/20 Okta options imply 9.8% move in share price post-earnings
Hot Stocks	NMI Holdings integrates with Mortech's product, pricing engine » 08:18 03/02/21 03/02 08:18 03/02/21 08:18 NMIH NMI Holdings $24.17 / +1.32 (+5.78%) National Mortgage… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate NMIH NMI Holdings $24.17 / +1.32 (+5.78%) 08:14 Today NMI Holdings reports 11,648 loans in default at Feb. 28 02/03/21 NMI Holdings reports 11,905 loans in default at Jan. 31 01/04/21 NMI Holdings reports 12,209 loans in default at Dec. 31 01/04/21 NMI Holdings announces new quota share reinsurance agreement NMIH NMI Holdings $24.17 / +1.32 (+5.78%) 01/04/21 BTIG NMI delinquency metrics release supports positive thesis, says BTIG 12/22/20 B. Riley Securities NMI Holdings price target raised to $30 from $26 at B. Riley Securities 12/17/20 BTIG NMI Holdings price target raised to $32 from $30 at BTIG 12/10/20 Barclays NMI Holdings price target raised to $32 from $26 at Barclays NMIH NMI Holdings $24.17 / +1.32 (+5.78%) 02/16/21 NMI Holdings reports Q4 EPS 59c, consensus 50c 11/05/20 NMI Holdings reports Q3 EPS 47c, consensus 35c 04 Jun
Hot Stocks	Elys Game comments on legislation to legalize single event Canada sport betting » 08:17 03/02/21 03/02 08:17 03/02/21 08:17 ELYS Elys Game Technology $6.60 / +0.68 (+11.49%) Elys Game Technology… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News ELYS Elys Game Technology $6.60 / +0.68 (+11.49%) 01/28/21 Elys Game Technology reports preliminary net gaming revenue $13.1M 12/30/20 Elys Game Technology commences trading on NEO Exchange 11/25/20 Elys Game Technology appoints Matteo Monteverdi CEO 11/10/20 Elys Game Technology changes name from Newgioco Group, changes symbol

Events

Earnings calls, analyst events, roadshows and more

TWND
Today at 08:30

Tailwind Acquisition - TWND Conference Calls
ANF
Today at 08:30

Abercrombie & Fitch - ANF Conference Calls
ATRS
Today at 08:30

Antares Pharma - ATRS Conference Calls
DDD
Today at 08:30

3D Systems - DDD Conference Calls
MDCA
Today at 08:30

MDC Partners - MDCA Conference Calls
KTB
Today at 08:30

Kontoor Brands - KTB Conference Calls
TTEC
Today at 08:30

TTEC Holdings - TTEC Conference Calls
TXMD
Today at 08:30

TherapeuticsMD - TXMD Conference Calls
WSTG
Today at 08:30

Wayside Technology - WSTG Conference Calls
KOPN
Today at 08:30

Kopin - KOPN Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	VRT X VRT Vertiv Holdings Block Trade Managers: JPMorgan Priced at: $20.70 17.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial KRTX X KRTX Karuna Therapeutics Secondary Managers: Goldman Sachs & JPMorgan Priced at: $120.00 2.08M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SYNH X SYNH Syneos Health Secondary Managers: Goldman Sachs Priced at: $74.95 7M Shares EAF X EAF GrafTech Spot Secondary Managers: Morgan Stanley Priced at: $11.88 30M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial JELD X JELD Jeld-Wen Spot Secondary Managers: Goldman Sachs Priced at: $29.25 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RCL X RCL Royal Caribbean Spot Secondary Managers: Morgan Stanley Priced at: $91.00 16.938M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SITC X SITC Site Centers Spot Secondary Managers: Morgan Stanley & Wells Fargo Priced at: $13.20 15M Shares WSC X WSC WillScot Mobile Mini Spot Secondary Managers: Morgan Stanley Priced at: $27.20 12.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	SWTX X SWTX SpringsWorks Therapeutics Block Trade Managers: Morgan Stanley $84.00-84.50 1.2M Shares FRC X FRC First Republic Spot Secondary Managers: BofA, JPMorgan & Morgan Stanley $166.50-169.95 1.5M Shares HLNE X HLNE Hamilton Lane Spot Secondary Managers: JPMorgan $88.25-89.25 1.45M Shares RDHL X RDHL RedHill Biopharma Spot Secondary Managers: H.C. Wainwright $9.23 1.25M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	GROY X GROY Gold Royalty IPO Managers: H.C. Wainwright & BMO Capital, CIBC, HAYW, Raymond James, Roth Capital, Scotiabank, Sprott, TD Securities $5.00 12M Shares OSCR X OSCR Oscar Health IPO Managers: Goldman Sachs, Morgan Stanley & Allen & Co., Wells Fargo, Credit Suisse, BofA, Cowen, LION, Ramirez, SIEB $32.00-34.00 31M Shares ASLN X ASLN Aslan Pharmaceuticals Secondary Managers: Jefferies & Piper Sandler $5.25 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CDLX X CDLX Cardlytics Secondary Managers: Wells Fargo, Raymond James $141.28 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial COHU X COHU Cohu Secondary Managers: Citi, Goldman Sachs & Stifel, B. Riley Securities, Craig-Hallum, DA Davidson $45.99 4.5M Shares HSKA X HSKA Heska Secondary Managers: JPMorgan & Piper Sandler $201.39 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial INDT X INDT Indus Realty Trust Secondary Managers: Morgan Stanley, Citi & Baird, BTIG, JMP Securities, JPMorgan $62.68 1.75M Shares MORF X MORF Morphic Secondary Managers: Jefferies, Cowen, BMO Capital & RBC Capital $84.85 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	INNV X INNV InnovAge IPO Managers: JPMorgan, Barclays, Goldman Sachs & Citi, Baird, William Blair, Piper Sandler, Capital One, Loop Capital, SIEB, Roberts & Ryans $17.00-19.00 16.667M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AMRK X AMRK A-Mark Precious Metals Secondary Managers: DA Davidson & Roth Capital, CIBC $27.97 2.5M Shares SLQT X SLQT SelectQuote Secondary Managers: Credit Suisse, Morgan Stanley, Goldman Sachs, RBC Capital, Barclays, Citi, Evercore ISI & Jefferies, Cantor Fitzgerald, Keefe Bruyette, Piper Sandler, Drexel Hamilton $32.22 10.6M Shares
Thurs	No deals
Fri	No deals

View All Syndicate Announcements »

FactSet price target raised to $260 from $225 at DA Davidson

TODAY'S FREE FLY STORIES

Get Full Fly Access